The Orphan Drug Act and the development of stem cell-based products for rare diseases

SID > Fuentes Documentales > Publicaciones Periódicas > Artículos de Revistas > The Orphan Drug Act and the development of stem cell-based products for rare diseases

Resumen

The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many conditions that stand to benefit from stem cell-based products are rare diseases. We address the Orphan Drug Act in relation to the development of stem cell-based products.

Resumen realizado por los autores recogido de la publicación

Publicación

Estados Unidos de América:
Cell Stem Cell,
2010

ISBN

Descripción física

283-287

Serie

Quizás te interese:

Recibe más documentos en tu email

No te pierdas todas nuestras actualizaciones